Sule Eraslan

Assistant Lecturer Sule Eraslan is affiliated with the Department of Cellular and Molecular Medicine at the University of Copenhagen, Denmark, based at Blegdamsvej 3, 2200 København N through the ICMM Teaching unit. Her work bridges cellular and molecular medicine with clinical gastroenterology applications.

Her research centers on gastrointestinal pathologies, particularly colorectal cancer resectability challenges and inflammatory bowel diseases (IBD) exacerbated by viral infections like COVID-19. She employs population-based cohort methodologies and molecular analysis to investigate patient outcomes in surgical and non-surgical contexts, emphasizing translational approaches from bench to bedside.

Recent publications (2022, 2025) reveal consistent focus on patient-centered gastrointestinal disorders through clinical data analysis. The 2022 IBD/COVID-19 study demonstrates epidemiological rigor with policy-relevant findings, while the 2025 colorectal cancer paper addresses critical gaps in surgical oncology decision-making. Both exemplify her commitment to precision medicine in digestive diseases through interdisciplinary collaboration.